Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and welcome to the Capricor's Third Quarter 2024 Financial Results and Corporate Update Call.
Capricor Therapeutics Inc. (CAPR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ikarian Capital Neil Shahrestani | 300,000 | $4,563,000 | 0.63% | |
| 2. | 300,000 | $4,563,000 | 0.63% | ||
| 3. | 300,000 | $4,563,000 | 0.63% | ||
| 4. | Altium Capital Jacob Gottlieb | 285,000 | $4,334,850 | 1.27% | |
| 5. | Point72 Asset Management Steve Cohen | 250,204 | $3,805,603 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.36 | 2,798,507 | 7,090,351 | 2024-09-20 | Filing | ||
| $2.75 | 410 | 31,536 | 2023-10-12 | Filing | ||
| $2.83 | 10,000 | 26,856 | 2023-10-10 | Filing | ||
| $2.82 | 5,083 | 31,126 | 2023-10-09 | Filing | ||
| $2.84 | 5,000 | 5,000 | 2023-10-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $64,258.00 | 14,772 | Other | 0 | 2023-04-17 | Filing | |
| $4.06 | 3,000 | 0 | 2023-03-28 | Filing | ||
| $3.77 | 28,215 | 12,747 | 2022-06-29 | Filing | ||
| $4.44 | 17,775 | 40,962 | 2022-06-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,165,404 | $5,698,826 | 0% | |
| 2. | 359,673 | $1,758,801 | 0% | |
| 3. | 316,198 | $1,546,507 | 0% | |
| 4. | 167,800 | $820,542 | 0% | |
| 5. | 149,115 | $729,172 | 0% |
News See All
10 Best Multibagger Stocks To Buy Heading into 2025
November has been an eventful month so far for the market as the Fed cut rates by a quarter percentage and president-elect, Donald Trump won the election for the second time.
7 Best Russell 2000 Stocks to Buy According to Analysts
The investor sentiment remains bullish toward the market, especially since the Fed's recent decision to cut interest rates by half a percentage point, which is seen as a move to sustain economic health...
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics Second Quarter 2024 Earnings Call. At this time, all participant lines are in a listen-only mode.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics First Quarter 2024 Earnings Call. At this time, all lines are in a listen-only mode.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2023 Earnings Call Transcript
Capricor Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.23. Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and welcome to the Capricor’s Third Quarter 2023 Financial Results and Corporate Update Call. This conference call is being recorded.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and welcome to the Capricor Therapeutics Second Quarter 2023 Financial Results and Corporate Update Call.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, this is the conference operator. Welcome to Capricor First Quarter 2023 Financial Results and Corporate Update Call.
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to Capricor Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Call. At this time, all participants are in a listen-only mode.